Traphagen Investment Advisors LLC Precigen, Inc. Transaction History
Traphagen Investment Advisors LLC
- $868 Million
- Q3 2024
A detailed history of Traphagen Investment Advisors LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 31,000 shares of PGEN stock, worth $25,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,000Holding current value
$25,420% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
140Shares Held
145MCall Options Held
292KPut Options Held
53.8K-
Third Security, LLC83.5MShares$68.4 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD18.2MShares$14.9 Million1.57% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$8.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.76MShares$5.54 Million0.0% of portfolio
-
Iridian Asset Management LLC3.78MShares$3.1 Million0.8% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $171M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...